These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 20853113)
1. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. Skau M; Sander B; Milea D; Jensen R J Neurol; 2011 Feb; 258(2):277-83. PubMed ID: 20853113 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Skau M; Yri H; Sander B; Gerds TA; Milea D; Jensen R Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):567-74. PubMed ID: 22592348 [TBL] [Abstract][Full Text] [Related]
3. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. ; Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807 [TBL] [Abstract][Full Text] [Related]
4. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension? Vosoughi AR; Margolin EA; Micieli JA J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748 [TBL] [Abstract][Full Text] [Related]
5. Idiopathic intracranial hypertension is not benign: a long-term outcome study. Yri HM; Wegener M; Sander B; Jensen R J Neurol; 2012 May; 259(5):886-94. PubMed ID: 22008872 [TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography represents a sensitive and reliable tool for routine monitoring of idiopathic intracranial hypertension with and without papilledema. Huang-Link Y; Eleftheriou A; Yang G; Johansson JM; Apostolou A; Link H; Jin YP Eur J Neurol; 2019 May; 26(5):808-e57. PubMed ID: 30586220 [TBL] [Abstract][Full Text] [Related]
7. Update on Idiopathic Intracranial Hypertension. Wall M Neurol Clin; 2017 Feb; 35(1):45-57. PubMed ID: 27886895 [TBL] [Abstract][Full Text] [Related]
8. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension. Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195 [TBL] [Abstract][Full Text] [Related]
9. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial. Dinkin MJ; Patsalides A J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959 [TBL] [Abstract][Full Text] [Related]
10. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Rebolleda G; Muñoz-Negrete FJ Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5197-200. PubMed ID: 19011007 [TBL] [Abstract][Full Text] [Related]
11. OCT for optic disc evaluation in idiopathic intracranial hypertension. Skau M; Milea D; Sander B; Wegener M; Jensen R Graefes Arch Clin Exp Ophthalmol; 2011 May; 249(5):723-30. PubMed ID: 20949278 [TBL] [Abstract][Full Text] [Related]
12. The Relationship between Lumbar Puncture Opening Pressure and Retinal Nerve Fiber Layer Thickness in the Diagnosis of Idiopathic Intracranial Hypertension: Is a Lumbar Puncture Always Necessary? Kaya Tutar N; Kale N Neurologist; 2024 Mar; 29(2):91-95. PubMed ID: 37839079 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension. Zaic S; Krajnc N; Macher S; Michl M; Müller N; Mitsch C; Marik W; Novak K; Wöber C; Pemp B; Bsteh G J Headache Pain; 2024 Sep; 25(1):145. PubMed ID: 39237912 [TBL] [Abstract][Full Text] [Related]
14. Impact of Pregnancy on Papilledema and Vision Loss in Idiopathic Intracranial Hypertension Patients: A Chart Review and Case Series of 13 Patients. Lambert-Cheatham NA; Nagia L; Pasmanter NR; Pellizzari R; Lee B; Miller NJ; Kaufman DI J Neuroophthalmol; 2024 Jun; 44(2):206-211. PubMed ID: 37540562 [TBL] [Abstract][Full Text] [Related]
15. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients. Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155 [TBL] [Abstract][Full Text] [Related]
16. Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension. Vijay V; Mollan SP; Mitchell JL; Bilton E; Alimajstorovic Z; Markey KA; Fong A; Walker JK; Lyons HS; Yiangou A; Tsermoulas G; Brock K; Sinclair AJ JAMA Ophthalmol; 2020 Dec; 138(12):1264-1271. PubMed ID: 33090189 [TBL] [Abstract][Full Text] [Related]
17. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. ; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513 [TBL] [Abstract][Full Text] [Related]
18. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. ; Wall M; McDermott MP; Kieburtz KD; Corbett JJ; Feldon SE; Friedman DI; Katz DM; Keltner JL; Schron EB; Kupersmith MJ JAMA; 2014 Apr 23-30; 311(16):1641-51. PubMed ID: 24756514 [TBL] [Abstract][Full Text] [Related]
19. Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension. Heckmann JG; Faschingbauer F; Lang C; Reulbach U; Dütsch M; Mardin CY; Schwab S J Neurosurg; 2007 Sep; 107(3):543-7. PubMed ID: 17886553 [TBL] [Abstract][Full Text] [Related]
20. Impact of weight reduction on structural and functional parameters of the optic nerve in idiopathic intracranial hypertension. Banerjee M; Phuljhele S; Saxena R; Sharma P; Misra V; Vibha D; Pandit AK Eur J Ophthalmol; 2024 Sep; 34(5):1594-1599. PubMed ID: 38380874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]